← Open Payments lookup

KRISTEN MAXWELL: Open Payments

NPI 1396353355 · DEMOREST, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$654 in 33 payments from 19 companies in 2025. Trend: 2023 $908 · 2024 $735 · 2025 $654

Food & beverage: $654
CompanyPaymentsAmount
Xeris Pharmaceuticals, Inc.4$86
Vanda Pharmaceuticals Inc.4$84
AstraZeneca Pharmaceuticals LP3$61
Otsuka America Pharmaceutical, Inc.2$48
ABBVIE INC.3$46
GlaxoSmithKline, LLC.2$44
Exact Sciences Corporation2$39
VERTEX PHARMACEUTICALS INCORPORATED1$35
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$29
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$24

Products named: GVOKE HYPOPEN, FANAPT, REXULTI, TRELEGY ELLIPTA, FARXIGA, Cologuard Collection Kit, JOURNAVX, UBRELVY.

Industry payments across GA — which companies pay providers there.